Is Wegovy FDA-approved?

FDA-approved for chronic weight management in adults with obesity or overweight with comorbidity (June 2021); FDA-approved for cardiovascular risk reduction in adults with established CVD (March 2024)

How much does Wegovy cost?

Wegovy costs vary significantly by provider and form. Brand-name versions can cost $1,000–$1,600/month without insurance. Compounded versions from telehealth providers typically range from $129–$400/month. See the cost comparison table above for current prices from top providers. Always check for manufacturer savings programs or telehealth promo codes.

Where can I get Wegovy?

Wegovy requires a prescription from a licensed healthcare provider. You can get it through your primary care doctor, endocrinologist, or a telehealth platform. Telehealth providers like those listed above typically offer faster access and lower out-of-pocket costs than traditional pharmacies for compounded versions.

✅FDA Reviewed📅Updated April 6, 2026

Wegovy Guide

Wegovy is the brand-name formulation of semaglutide 2.4mg, specifically FDA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition. It is a weekly subcutaneous injection developed by Novo Nordisk.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

At a Glance

Generic Name	Semaglutide
Brand Names	Wegovy
FDA Status	FDA-approved for chronic weight management in adults with obesity or overweight with comorbidity (June 2021); FDA-approved for cardiovascular risk reduction in adults with established CVD (March 2024)
Approval Date	June 4, 2021

How Wegovy Works

Wegovy delivers semaglutide 2.4mg — the highest approved dose — via once-weekly self-injection. It mimics the GLP-1 hormone to signal fullness to the brain, slow stomach emptying, and reduce overall caloric intake. The higher 2.4mg dose was specifically engineered to maximize the weight-loss effect beyond the 1mg dose used for diabetes.

Dosing Schedule

Wegovy uses a gradual dose escalation to minimize side effects. Always follow your prescriber's guidance.

Weeks 1–40.25mg/week

Weeks 5–80.5mg/week

Weeks 9–121.0mg/week

Weeks 13–161.7mg/week

Week 17+2.4mg/week (maintenance)

Side Effects

Common: nausea (44%), diarrhea (30%), vomiting (24%), constipation (24%), abdominal pain (20%), headache, fatigue. Side effects typically peak during dose escalation and diminish within 4–8 weeks. Serious (rare): pancreatitis, gallstones, kidney injury, heart rate increase, suicidal ideation (under review by FDA).

This is not a complete list. Consult your healthcare provider or prescriber for full safety information.

Clinical Trial Results

The STEP-1 trial showed Wegovy users lost an average of 14.9% of body weight (about 34 lbs) over 68 weeks compared to 2.4% in placebo. The SELECT cardiovascular outcomes trial (N=17,604) demonstrated a 20% reduction in major adverse cardiovascular events in obese patients with established CVD.
Source: Published clinical trial data (STEP / SURMOUNT trial series)

Where to Get Wegovy

These telehealth providers offer access to semaglutide or compounded equivalents with online consultations and home delivery.

CoreAge Rx

Best for: best overall value

9.0

★★★★★4.7 (850)

$149/mo

CompoundedFree 2-Day Shipping24/7 SupportLegitScript Verified

Get Started